You are here: Industry Insights > Autism

News List

Increased Risk for Mortality Seen for Persons With Autism, ADHD drugs.com
February 14, 2022
The risk for mortality is increased significantly for persons with autism spectrum disorders (ASD) and those with attention-deficit/hyperactivity...
'Preemie' Babies More Vulnerable to Autism Diagnosis Later: Study drugs
August 12, 2021
Babies born prematurely, even just a couple weeks early, may be at increased risk of autism, a large new study suggests.
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism prnasia
August 05, 2021
The Faculty of Medicine of The Chinese University of Hong Kong, S.A.R., China (CU Medicine) reports a ground breaking discovery that children with autism spectrum disorder (autism) showed delayed gut microbiome maturity compared with typically developing
Gov’t reveals new strategy to improve support and care for autistic people pharmatimes
July 22, 2021
A new multi-million pound strategy aimed at improving support and care for autistic people has been launched by the government 21st.
Telehealth: Tips for Helping Kids With Autism Take Part drugs
July 06, 2021
Telehealth is increasing in popularity in the United States, partly due to the pandemic. But some children with autism have difficulty sitting through these virtual appointments.
PAX-101 meaningfully improves core symptoms of autism europeanpharmaceuticalreview
February 25, 2021
In a phase II trial, PAX-101 (IV suramin) significantly improved symptoms in children with moderate to severe autism spectrum disorder (ASD).
MapLight Completes Dosing in Phase 1 Study for Social Deficit in Autism americanpharmaceuticalreview
December 09, 2020
MapLight Therapeutics has completed dosing of healthy volunteers across five cohorts in a Phase 1 clinical trial evaluating the safety of ML-004, a selective serotonin receptor agonist.
Sangamo, Novartis Partner to Develop Gene Therapies for Autism contractpharma
July 31, 2020
Sangamo will receive $75M upfront and is eligible to receive up to $720M in potential milestones for three neurodevelopmental targets.
New research discovers cells linked to Alzheimer’s and autism pharmatimes
March 18, 2020
New research by scientists at the Wellcome Sanger Institute has discovered cells that could be linked to both Alzheimer’s and autism.
Severity of Autism Symptoms May Vary in Monozygotic Twins drugs
January 02, 2020
Autism spectrum disorder (ASD) is markedly heritable, with probandwise concordance of 96 percent, but there is variation in the severity of symptomatology above the diagnostic threshold ...

Previous page 1 2 3 4 Next page